Item Type | Name |
Concept
|
Cluster Headache
|
Concept
|
Headache
|
Concept
|
Headache Disorders
|
Concept
|
Headache Disorders, Primary
|
Concept
|
Headache Disorders, Secondary
|
Concept
|
Post-Traumatic Headache
|
Concept
|
Post-Dural Puncture Headache
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
|
Academic Article
|
Defining the pharmacologically intractable headache for clinical trials and clinical practice.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: a response.
|
Academic Article
|
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Migraine headache is present in the aura phase: a prospective study.
|
Academic Article
|
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches - a narrative review.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
|
Academic Article
|
Migraine genetics - a review: part I.
|
Academic Article
|
Migraine Genetics: Part II.
|
Academic Article
|
Is there a preferred triptan?
|
Academic Article
|
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
|
Academic Article
|
Cardiovascular tolerability and safety of triptans: a review of clinical data.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
|
Academic Article
|
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
|
Academic Article
|
DHE in the pharmacotherapy of migraine: potential for a larger role.
|
Academic Article
|
Central sensitization theory of migraine: clinical implications.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
|
Academic Article
|
Operational diagnostic criteria for chronic migraine: expert opinion.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Late-life migraine accompaniments: A narrative review.
|
Academic Article
|
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
|
Academic Article
|
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations.
|
Academic Article
|
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
|
Academic Article
|
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
|
Academic Article
|
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
|
Academic Article
|
Pathophysiology, prevention, and treatment of medication overuse headache.
|
Academic Article
|
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
|
Academic Article
|
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
|
Academic Article
|
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.
|
Academic Article
|
Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
|
Academic Article
|
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.
|
Academic Article
|
Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR).
|
Academic Article
|
Chronic daily headache: an evidence-based and systematic approach to a challenging problem.
|
Academic Article
|
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
|
Academic Article
|
Question & answer session.
|
Academic Article
|
Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders.
|
Academic Article
|
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
|
Academic Article
|
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
|
Academic Article
|
Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology.
|
Academic Article
|
Headache.
|
Academic Article
|
The Sinus, Allergy and Migraine Study (SAMS).
|
Academic Article
|
Atypical age-related cortical thinning in episodic migraine.
|
Academic Article
|
Adherence to oral migraine-preventive medications among patients with chronic migraine.
|
Academic Article
|
Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache.
|
Academic Article
|
From hemicrania lunaris to hemicrania continua: an overview of the revised International Classification of Headache Disorders.
|
Academic Article
|
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
|
Academic Article
|
Duration of migraine is a predictor for response to botulinum toxin type A.
|
Academic Article
|
Imploding and exploding migraine headaches: comparison of methods to diagnose pain directionality.
|
Academic Article
|
Response to Letter to the Editor.
|
Academic Article
|
Clinical, anatomical, and physiologic relationship between sleep and headache.
|
Academic Article
|
CASE 1: the well-intentioned triptan prescriber.
|
Academic Article
|
Evaluation of cutaneous allodynia following induction of cortical spreading depression in freely moving rats.
|
Academic Article
|
Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
|
Academic Article
|
Painful ophthalmoplegia: overview with a focus on Tolosa-Hunt syndrome.
|
Academic Article
|
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
|
Academic Article
|
Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
|
Academic Article
|
Proposed new diagnostic criteria for chronic migraine.
|
Academic Article
|
A not so uncommon cause of thunderclap headache.
|
Academic Article
|
Clomiphene citrate as a new treatment for SUNCT: hormonal manipulation for hypothalamic-influenced trigeminal autonomic cephalalgias.
|
Academic Article
|
Diagnosis and treatment of cluster headache.
|
Academic Article
|
Hemicrania continua secondary to an ipsilateral brainstem lesion.
|
Academic Article
|
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
|
Academic Article
|
Extracephalic cluster (cluster sine headache).
|
Academic Article
|
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
|
Academic Article
|
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.
|
Academic Article
|
Googling migraine: A study of Google as an information resource of migraine management.
|
Academic Article
|
Identifying migraine in primary care settings.
|
Academic Article
|
Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review.
|
Academic Article
|
Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
|
Academic Article
|
Sporadic hemiplegic migraine with permanent neurological deficits.
|
Academic Article
|
Sustained-release niacin for prevention of migraine headache.
|
Academic Article
|
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis.
|
Academic Article
|
Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache.
|
Academic Article
|
Chronic daily headache: a rational approach to a challenging problem.
|
Academic Article
|
Sentinel headache.
|
Academic Article
|
Headache attributed to non-vascular intracranial disorder.
|
Academic Article
|
Vancouver Declaration on Global Headache Patient Advocacy 2018.
|
Academic Article
|
The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
|
Academic Article
|
Revised 2004 International Classification of Headache Disorders: new headache types.
|
Academic Article
|
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment.
|
Academic Article
|
Patent foramen ovale and migraine.
|
Academic Article
|
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
|
Academic Article
|
Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
|
Academic Article
|
A Phase-by-Phase Review of Migraine Pathophysiology.
|
Academic Article
|
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
|
Academic Article
|
Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
|
Academic Article
|
Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.
|
Academic Article
|
Thunderclap headache.
|
Academic Article
|
Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.
|
Academic Article
|
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic.
|
Academic Article
|
Headache: challenging conventional wisdom.
|
Academic Article
|
Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
|
Academic Article
|
CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
|
Academic Article
|
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies.
|
Academic Article
|
2007 Scottsdale Headache Symposium.
|
Academic Article
|
Headache attributed to disorders of homeostasis.
|
Academic Article
|
[123I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: A case series.
|
Academic Article
|
Vancouver Declaration II on Global Headache Patient Advocacy 2019.
|
Academic Article
|
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.
|
Academic Article
|
Evidence-based understanding of medication-overuse headache: clinical implications.
|
Academic Article
|
Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies?
|
Academic Article
|
Refractory headaches due to multilevel thoracic cerebrospinal fluid leaks.
|
Academic Article
|
Cephalalgia has flourished over the past 8 years under its publisher, Wiley-Blackwell.
|
Academic Article
|
Occipital nerve stimulation: technical and surgical aspects of implantation.
|
Academic Article
|
Posttraumatic headache.
|
Academic Article
|
Letter from the Editor-in-Chief.
|
Academic Article
|
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
|
Academic Article
|
Simvastatin for migraine prevention.
|
Academic Article
|
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
|
Academic Article
|
Headache research: a string of pearls.
|
Academic Article
|
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM).
|
Academic Article
|
Headache research in 2015: progress in migraine treatment.
|
Academic Article
|
The Non-Inferiority Margins in Migraine Research (NIMM) Survey.
|
Academic Article
|
How pain, including headache, becomes chronic.
|
Academic Article
|
Identifying the factors underlying discontinuation of triptans.
|
Academic Article
|
Re: Placebo responses in device studies.
|
Academic Article
|
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Journal report from the Editor.
|
Academic Article
|
Treatment of medication-overuse headache: A systematic review.
|
Academic Article
|
Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research.
|
Academic Article
|
Ten most commonly asked questions about headaches associated with spontaneous cerebrospinal fluid leaks... with one bonus question!
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
|
Academic Article
|
Pathophysiology and management of transformed migraine and medication overuse headache.
|
Academic Article
|
Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894.
|
Academic Article
|
The scientific basis of migraine.
|
Academic Article
|
Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache.
|
Academic Article
|
Triptan nonresponder studies: implications for clinical practice.
|
Academic Article
|
Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literature.
|
Academic Article
|
Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies.
|
Academic Article
|
IHS: sustaining momentum, fostering collaboration, facilitating advocacy.
|
Academic Article
|
SUNCT responsive to gabapentin.
|
Academic Article
|
Prolonged neurologic complication and MRI abnormalities consequent to intracranial hypotension.
|
Academic Article
|
Thunderclap headache.
|
Academic Article
|
Examining the essence of migraine--is it the blood vessel or the brain? A debate.
|
Academic Article
|
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
|
Academic Article
|
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
|
Academic Article
|
Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine.
|
Academic Article
|
Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak.
|
Academic Article
|
Reply to Dr. Merry's Letter to the Editor.
|
Academic Article
|
Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
|
Academic Article
|
Tearing without pain after trigeminal root section for cluster headache.
|
Academic Article
|
Occipital nerve stimulation for headache: mechanisms and efficacy.
|
Academic Article
|
Pearls: headache.
|
Academic Article
|
Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine.
|
Academic Article
|
Migraine triggers.
|
Academic Article
|
The effect of prophylactic medications on TMS for migraine aura.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
|
Academic Article
|
Thunderclap headache: an approach to a neurologic emergency.
|
Academic Article
|
Taking the headache out of migraine.
|
Academic Article
|
Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
|
Academic Article
|
Familial hemiplegic migraine: permanent attack-related neurologic deficits.
|
Academic Article
|
The face of chronic migraine: epidemiology, demographics, and treatment strategies.
|
Academic Article
|
Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings.
|
Academic Article
|
Migraine and the vascular system: much has been learned but still a long way to go.
|
Academic Article
|
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
|
Academic Article
|
Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
|
Academic Article
|
Board Walk - September 2017.
|
Academic Article
|
Acute treatment patterns in patients with migraine newly initiating a triptan.
|
Academic Article
|
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.
|
Academic Article
|
Treatment of chronic migraine.
|
Academic Article
|
Academic dissertations from the Danish Headache Center 1980-2016.
|
Academic Article
|
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
|
Academic Article
|
The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving =50%, =75%, and 100% Response.
|
Academic Article
|
Introduction: cardiovascular safety and triptans in the acute treatment of migraine.
|
Academic Article
|
Indomethacin-responsive headache syndromes.
|
Academic Article
|
55-Year-old man with thunderclap headache.
|
Academic Article
|
Reversible cerebral vasoconstriction syndrome.
|
Academic Article
|
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
|
Academic Article
|
Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study.
|
Academic Article
|
Preventing migraine pharmacologically.
|
Academic Article
|
Clinical practice. Chronic daily headache.
|
Academic Article
|
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
|
Academic Article
|
Percutaneous occipital stimulator lead tip erosion: report of 2 cases.
|
Academic Article
|
Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
|
Academic Article
|
"Occult" orthostatic headache.
|
Academic Article
|
Spontaneous intracranial hypotension.
|
Academic Article
|
Duplicate publication.
|
Academic Article
|
Triptan-induced latent sensitization: a possible basis for medication overuse headache.
|
Academic Article
|
Transcranial magnetic stimulation for migraine: a safety review.
|
Academic Article
|
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
|
Academic Article
|
Procedural Headache Medicine in Neurology Residency Training: A Survey of US Program Directors.
|
Academic Article
|
Post-traumatic headache: epidemiology and pathophysiological insights.
|
Academic Article
|
Spontaneous CSF leak treated with percutaneous CT-guided fibrin glue.
|
Academic Article
|
Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headache.
|
Academic Article
|
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
|
Academic Article
|
Epidemiology and acute care of migraine headache.
|
Academic Article
|
Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth.
|
Academic Article
|
Current and emerging treatment options for migraine and other primary headache disorders.
|
Academic Article
|
Board walk - December 2013.
|
Academic Article
|
Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
|
Academic Article
|
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
|
Academic Article
|
Thunderclap headache.
|
Academic Article
|
The young woman with postpartum "thunderclap" headache.
|
Academic Article
|
The headaches that awaken us.
|
Academic Article
|
Cluster headache: diagnosis and treatment.
|
Academic Article
|
Thunderclap stroke: embolic cerebellar infarcts presenting as thunderclap headache.
|
Academic Article
|
Suboccipital steroid injections for cluster headache.
|
Academic Article
|
Patent foramen ovale and migraine--bringing closure to the subject.
|
Academic Article
|
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache.
|
Academic Article
|
Therapeutic guidelines for headache.
|
Academic Article
|
Triptan education and improving knowledge for optimal migraine treatment: an observational study.
|
Academic Article
|
Refractory headaches treated with bilateral occipital and temporal region stimulation.
|
Academic Article
|
The migraine landscape on YouTube: A review of YouTube as a source of information on migraine.
|
Academic Article
|
Management of chronic daily headache: challenges in clinical practice.
|
Academic Article
|
Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache.
|
Academic Article
|
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
|
Academic Article
|
Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
|
Academic Article
|
Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II.
|
Academic Article
|
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing.
|
Academic Article
|
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
|
Academic Article
|
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
|
Academic Article
|
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
|
Academic Article
|
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
|
Academic Article
|
Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
|
Academic Article
|
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.
|
Academic Article
|
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
|
Academic Article
|
Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.
|
Academic Article
|
Real-world efficacy, tolerability, and safety of ubrogepant.
|
Academic Article
|
Impact of abuse on migraine-related sensory hypersensitivity symptoms: Results from the American Registry for Migraine Research.
|
Academic Article
|
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
|
Academic Article
|
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.
|
Academic Article
|
Systematic review of outcomes and endpoints in acute migraine clinical trials.
|
Academic Article
|
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
|
Academic Article
|
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
|
Academic Article
|
Systematic review of outcomes and endpoints in preventive migraine clinical trials.
|
Academic Article
|
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis.
|
Academic Article
|
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey study.
|
Academic Article
|
Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.
|
Academic Article
|
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
|
Academic Article
|
Mild traumatic brain injury affects the features of migraine.
|
Academic Article
|
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
|
Academic Article
|
Patient-identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient-centered outcome.
|
Academic Article
|
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
|
Academic Article
|
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
|
Academic Article
|
Medication-overuse headache in patients with secondary headache disorders: Need for revision?
|
Academic Article
|
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data.
|
Academic Article
|
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine.
|
Academic Article
|
Diagnosing Secondary and Primary Headache Disorders.
|
Academic Article
|
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine.
|
Academic Article
|
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
|
Academic Article
|
Post-traumatic Headache: Pharmacologic Management and Targeting CGRP Signaling.
|
Academic Article
|
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.
|
Academic Article
|
Narrative review: reversible cerebral vasoconstriction syndromes.
|
Academic Article
|
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review.
|
Academic Article
|
Treatment of chronic migraine with medication overuse: A perspective.
|
Academic Article
|
The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research.
|
Academic Article
|
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition.
|
Academic Article
|
Giant cell arteritis.
|
Academic Article
|
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.
|
Academic Article
|
Third gene identified for hereditary headache.
|
Academic Article
|
Evaluating the clinical utility of the patient-identified most bothersome symptom measure from PROMISE-2 for research in migraine prevention.
|
Academic Article
|
Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men.
|
Academic Article
|
Exploring the association between migraine and atrial fibrillation utilizing a novel artificial intelligence-ECG algorithm.
|
Academic Article
|
Management of Trigeminal Autonomic Cephalalgias Including Chronic Cluster: A Review.
|
Academic Article
|
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?
|
Academic Article
|
Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.
|
Academic Article
|
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing-off of erenumab within monthly treatment cycle.
|
Academic Article
|
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.
|
Academic Article
|
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence.
|
Academic Article
|
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks.
|